U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 19

1.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
John J. Lima, Cameron D. Thomas, Julia Barbarino, Zeruesenay Desta, Sara L. Van Driest, Nihal El Rouby, Julie A. Johnson, Larisa H. Cavallari, Valentina Shakhnovich, David L. Thacker, Stuart A. Scott, Matthias Schwab, Chakradhara Rao S Uppugunduri, Christine M. Formea, James P. Franciosi, Katrin Sangkuhl, Andrea Gaedigk, Teri E. Klein, Roseann S. Gammal, Takahisa Furuta
Clin Pharmacol Ther. Author manuscript; available in PMC 2022 Jun 1.
Published in final edited form as: Clin Pharmacol Ther. 2021 Jun; 109(6): 1417–1423. Published online 2020 Sep 20. doi: 10.1002/cpt.2015
PMCID:
PMC7868475
AbstractArticlePDF–84K
2.
CYP2C19 Allele Frequencies in Over 2.2 Million Direct‐to‐Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System
Yelena Ionova, James Ashenhurst, Jianan Zhan, Hoang Nhan, Cindy Kosinski, Bani Tamraz, Alison Chubb
Clin Transl Sci. 2020 Nov; 13(6): 1298–1306. Published online 2020 Jul 21. doi: 10.1111/cts.12830
PMCID:
PMC7719394
AbstractArticlePDF–373K
3.
CYP2C19 Phenotype and Risk of Proton Pump Inhibitor–Associated Infections
Christiana J. Bernal, Ida Aka, Robert J. Carroll, Joseph R. Coco, John J. Lima, Sari A. Acra, Dan M. Roden, Sara L. Van Driest
Pediatrics. 2019 Dec; 144(6): e20190857. Published online 2019 Dec 2. doi: 10.1542/peds.2019-0857
PMCID:
PMC6889971
AbstractArticlePDF–663K
4.
Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles
Mariana R. Botton, Xingwu Lu, Geping Zhao, Elena Repnikova, Yoshinori Seki, Andrea Gaedigk, Eric E. Schadt, Lisa Edelmann, Stuart A. Scott
Hum Mutat. Author manuscript; available in PMC 2020 Nov 1.
Published in final edited form as: Hum Mutat. 2019 Nov; 40(11): e37–e51. doi: 10.1002/humu.23855
PMCID:
PMC6810756
AbstractArticlePDF–462K
5.
Novel Implementation of Genotype‐Guided Proton Pump Inhibitor Medication Therapy in Children: A Pilot, Randomized, Multisite Pragmatic Trial
Emily J. Cicali, Kathryn Blake, Yan Gong, Edward B. Mougey, Hadeel Al‐Atrash, Nancy Chambers, Jolanda Denham, Jonathan Evans, Donald E. George, Roberto Gomez, Pablo Palomo, Salik Taufiq, Julie A. Johnson, John J. Lima, James P. Franciosi
Clin Transl Sci. 2019 Mar; 12(2): 172–179. Published online 2018 Oct 20. doi: 10.1111/cts.12589
PMCID:
PMC6440564
AbstractArticlePDF–285K
6.
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara
J Neurogastroenterol Motil. 2018 Apr; 24(2): 182–196. Published online 2018 Apr 1. doi: 10.5056/jnm18001
PMCID:
PMC5885718
AbstractArticlePDF–312K
7.
A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease
L. Hillman, R. Yadlapati, A. J. Thuluvath, M. A. Berendsen, J. E. Pandolfino
Dis Esophagus. 2017 Sep; 30(9): 1–15. Published online 2017 Jul 19. doi: 10.1093/dote/dox055
PMCID:
PMC5788178
AbstractArticlePDF–898K
8.
Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children
Ida Aka, Christiana J. Bernal, Robert Carroll, Angela Maxwell-Horn, Kazeem A. Oshikoya, Sara L. Van Driest
J Pers Med. 2017 Dec; 7(4): 14. Published online 2017 Nov 2. doi: 10.3390/jpm7040014
PMCID:
PMC5748626
AbstractArticlePDF–453K
9.
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update
J. Kevin Hicks, Katrin Sangkuhl, Jesse J. Swen, Vicki L. Ellingrod, Daniel J. Müller, Kazutaka Shimoda, Jeffrey R. Bishop, Evan D. Kharasch, Todd C. Skaar, Andrea Gaedigk, Henry M. Dunnenberger, Teri E. Klein, Kelly E. Caudle, Julia C. Stingl
Clin Pharmacol Ther. Author manuscript; available in PMC 2018 Jun 20.
Published in final edited form as: Clin Pharmacol Ther. 2017 Jul; 102(1): 37–44. Published online 2017 Feb 13. doi: 10.1002/cpt.597
PMCID:
PMC5478479
AbstractArticlePDF–166K
10.
Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy
Brad Moriyama, Aniwaa Owusu Obeng, Julia Barbarino, Scott R. Penzak, Stacey A. Henning, Stuart A. Scott, José A. G. Agúndez, John R. Wingard, Howard L McLeod, Teri E. Klein, Shane Cross, Kelly E. Caudle, Thomas J. Walsh
Clin Pharmacol Ther. Author manuscript; available in PMC 2018 Jun 16.
Published in final edited form as: Clin Pharmacol Ther. 2017 Jul; 102(1): 45–51. Published online 2017 Apr 18. doi: 10.1002/cpt.583
PMCID:
PMC5474211
AbstractArticlePDF–333K
11.
Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori
Yun-An Lin, Hong Wang, Zhu-Jun Gu, Wen-Jia Wang, Xiao-Yan Zeng, Yan-Lei Du, Song-Song Ying, Bo-Hua Zhang
Med Sci Monit. 2017; 23: 2701–2707. Published online 2017 Jun 3. doi: 10.12659/MSM.901514
PMCID:
PMC5467706
AbstractArticlePDF–477K
12.
Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers
Sunny Park, Yang Jin Hyun, Yu Ran Kim, Ju Hyun Lee, Sunae Ryu, Jeong Mi Kim, Woo-Yong Oh, Han Sung Na, Jong Gu Lee, Doo Won Seo, In Yeong Hwang, Zewon Park, In-Jin Jang, Jaeseong Oh, Seung Eun Choi
J Korean Med Sci. 2017 May; 32(5): 729–736. Published online 2017 Mar 16. doi: 10.3346/jkms.2017.32.5.729
PMCID:
PMC5383603
AbstractArticlePDF–447K
13.
Rapid and ultra-rapid metabolizers with CYP2C19*17 polymorphism do not respond to standard therapy with proton pump inhibitors
Neha Deshpande, Sharanya V., Ravi Kanth V. V., Murthy H. V. V., Sasikala M., Rupa Banerjee, Manu Tandan, Nageshwar Reddy D.
Meta Gene. 2016 Sep; 9: 159–164. Published online 2016 Jun 18. doi: 10.1016/j.mgene.2016.06.004
PMCID:
PMC4932617
AbstractArticlePDF–258K
14.
Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting
Lisa V. Kalman, José A.G. Agúndez, Malin Lindqvist Appell, John Logan Black, Gillian C. Bell, Sotiria Boukouvala, Carsten Bruckner, Elspeth Bruford, Carsten Bruckner, Kelly Caudle, Sally Coulthard, Ann K. Daly, Andria L. Del Tredici, Johan T den Dunnen, Katarzyna Drozda, Robin Everts, David Flockhart, Robert Freimuth, Andrea Gaedigk, Houda Hachad, Toinette Hartshorne, Magnus Ingelman-Sundberg, Teri E. Klein, Volker M. Lauschke, Donna R. Maglott, Howard L. McLeod, Gwendolyn A. McMillin, Urs A. Meyer, Daniel J. Müller, Deborah A. Nickerson, William S. Oetting, Michael Pacanowski, Victoria M. Pratt, Mary V. Relling, Ali Roberts, Wendy S. Rubinstein, Katrin Sangkuhl, Matthias Schwab, Stuart A. Scott, Sarah C Sim, Ranjit K Thirumaran, Lorraine H. Toji, Rachel Tyndale, Ron HN van Schaik, Michelle Whirl-Carrillo, Kiang-Teck J Yeo, Ulrich M. Zanger
Clin Pharmacol Ther. Author manuscript; available in PMC 2017 Feb 1.
Published in final edited form as: Clin Pharmacol Ther. 2016 Feb; 99(2): 172–185. Published online 2015 Nov 20. doi: 10.1002/cpt.280
PMCID:
PMC4724253
AbstractArticlePDF–673K
15.
Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication
Annie Guérin, Reema Mody, Valerie Carter, Charles Ayas, Haridarshan Patel, Karen Lasch, Eric Wu
PLoS One. 2016; 11(1): e0145504. Published online 2016 Jan 4. doi: 10.1371/journal.pone.0145504
PMCID:
PMC4699636
AbstractArticlePDF–414K
16.
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors
Charles E. Leonard, Warren B. Bilker, Colleen M. Brensinger, David A. Flockhart, Cristin P. Freeman, Scott E. Kasner, Stephen E. Kimmel, Sean Hennessy
Stroke. Author manuscript; available in PMC 2016 Mar 1.
Published in final edited form as: Stroke. 2015 Mar; 46(3): 722–731. Published online 2015 Feb 5. doi: 10.1161/STROKEAHA.114.006866
PMCID:
PMC4342326
AbstractArticlePDF–575K
17.
Antiplatelet drug interactions with proton pump inhibitors
Stuart A Scott, Aniwaa Owusu Obeng, Jean-Sébastien Hulot
Expert Opin Drug Metab Toxicol. Author manuscript; available in PMC 2015 Feb 1.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2014 Feb; 10(2): 175–189. Published online 2013 Nov 9. doi: 10.1517/17425255.2014.856883
PMCID:
PMC4110685
AbstractArticlePDF–753K
18.
Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect
Gregory L. Kearns, J. Steven Leeder, Andrea Gaedigk
Drug Metab Dispos. 2010 Jun; 38(6): 894–897. doi: 10.1124/dmd.109.030601
PMCID:
PMC2879959
AbstractArticlePDF–249K
19.
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
R Michael Baldwin, Staffan Ohlsson, Rasmus Steen Pedersen, Jessica Mwinyi, Magnus Ingelman-Sundberg, Erik Eliasson, Leif Bertilsson
Br J Clin Pharmacol. 2008 May; 65(5): 767–774. Published online 2008 Feb 20. doi: 10.1111/j.1365-2125.2008.03104.x
PMCID:
PMC2432489
AbstractArticlePDF–662K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center